Gabelli Funds’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.5M Sell
144,850
-2,500
-2% -$219K 0.08% 299
2026
Q1
$13.3M Buy
147,350
+17,000
+13% +$1.56M 0.09% 270
2025
Q4
$11.7M Buy
130,350
+14,400
+12% +$1.37M 0.08% 287
2025
Q3
$11.4M Buy
115,950
+500
+0.4% +$49.5K 0.08% 297
2025
Q2
$10.5M Buy
115,450
+4,500
+4% +$435K 0.07% 306
2025
Q1
$12.6M Sell
110,950
-4,300
-4% -$460K 0.1% 263
2024
Q4
$12.2M Sell
115,250
-500
-0.4% -$53.6K 0.09% 272
2024
Q3
$12.5M Buy
115,750
+6,200
+6% +$677K 0.09% 278
2024
Q2
$11.9M Sell
109,550
-5,000
-4% -$589K 0.09% 278
2024
Q1
$15.1M Hold
114,550
0.11% 242
2023
Q4
$13.9M Sell
114,550
-4,400
-4% -$491K 0.11% 244
2023
Q3
$13.3M Buy
118,950
+3,000
+3% +$381K 0.11% 246
2023
Q2
$16.9M Sell
115,950
-5,700
-5% -$775K 0.13% 211
2023
Q1
$15.7M Sell
121,650
-1,400
-1% -$176K 0.12% 233
2022
Q4
$15.7M Buy
123,050
+500
+0.4% +$58K 0.12% 230
2022
Q3
$12.8M Sell
122,550
-1,900
-2% -$209K 0.11% 253
2022
Q2
$13.1M Buy
124,450
+3,400
+3% +$403K 0.1% 277
2022
Q1
$15.5M Sell
121,050
-21,657
-15% -$2.61M 0.1% 262
2021
Q4
$17.6M Sell
142,707
-463
-0.3% -$60.6K 0.11% 232
2021
Q3
$20.3M Buy
143,170
+5,098
+4% +$750K 0.13% 204
2021
Q2
$21.6M Buy
138,072
+6,335
+5% +$1.03M 0.14% 204
2021
Q1
$20.5M Buy
131,737
+51
+0% +$7.9K 0.14% 200
2020
Q4
$19.7M Sell
131,686
-206
-0.2% -$29.1K 0.14% 189
2020
Q3
$17.4M Buy
131,892
+515
+0.4% +$67.3K 0.14% 189
2020
Q2
$15.2M Sell
131,377
-25
-0% -$2.88K 0.12% 213
2020
Q1
$12.9M Sell
131,402
-5,691
-4% -$746K 0.11% 237
2019
Q4
$19.9M Sell
137,093
-9,270
-6% -$1.28M 0.13% 218
2019
Q3
$19.5M Sell
146,363
-14,111
-9% -$1.82M 0.13% 217
2019
Q2
$18.3M Sell
160,474
-4,944
-3% -$579K 0.12% 234
2019
Q1
$20.5M Sell
165,418
-14,626
-8% -$1.66M 0.13% 220
2018
Q4
$18.1M Sell
180,044
-19,570
-10% -$2.2M 0.12% 232
2018
Q3
$25.5M Sell
199,614
-3,914
-2% -$465K 0.15% 209
2018
Q2
$22M Sell
203,528
-12,978
-6% -$1.41M 0.13% 231
2018
Q1
$22.9M Buy
216,506
+7,931
+4% +$921K 0.14% 217
2017
Q4
$24.4M Buy
208,575
+10,506
+5% +$1.19M 0.14% 216
2017
Q3
$22.5M Buy
198,069
+52,736
+36% +$6.09M 0.13% 221
2017
Q2
$18.1M Buy
145,333
+1,545
+1% +$183K 0.11% 260
2017
Q1
$17M Buy
143,788
+14,523
+11% +$1.65M 0.1% 276
2016
Q4
$13M Buy
129,265
+9,270
+8% +$994K 0.08% 329
2016
Q3
$15.1M Sell
119,995
-2,575
-2% -$318K 0.09% 299
2016
Q2
$14.3M Hold
122,570
0.08% 313
2016
Q1
$12.7M Buy
122,570
+10,300
+9% +$996K 0.08% 329
2015
Q4
$11.2M Sell
112,270
-20,600
-16% -$2.02M 0.07% 362
2015
Q3
$12.1M Buy
132,870
+4,944
+4% +$496K 0.07% 354
2015
Q2
$13.6M Buy
127,926
+28,222
+28% +$3.12M 0.07% 360
2015
Q1
$11.4M Hold
99,704
0.06% 401
2014
Q4
$11M Buy
99,704
+206
+0.2% +$21.7K 0.05% 415
2014
Q3
$9.71M Hold
99,498
0.05% 442
2014
Q2
$10M Hold
99,498
0.05% 440
2014
Q1
$9.14M Buy
99,498
+10,300
+12% +$949K 0.05% 438
2013
Q4
$8.07M Hold
89,198
0.04% 452
2013
Q3
$7.11M Sell
89,198
-1,442
-2% -$114K 0.04% 473
2013
Q2
$6.59M Buy
+90,640
New +$6.78M 0.04% 462

Other funds holding ZBH

Gabelli Funds's ZBH Position: Q2 2026 in Review

Gabelli Funds reduced its Zimmer Biomet (ZBH) stake by 1.7% in Q2 2026, selling an estimated $219K and leaving 144,850 shares worth $12.5M. The position accounts for 0.08% of the portfolio, ranked #299.

Gabelli Funds first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $25.5M in Q3 2018. 904 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Gabelli Funds held 144,850 shares of Zimmer Biomet worth $12.5M as of Q2 2026.
  • Gabelli Funds sold 2,500 Zimmer Biomet shares in Q2 2026, an estimated $219K.
  • Zimmer Biomet made up 0.08% of Gabelli Funds's portfolio in Q2 2026, its #299 holding.
  • Gabelli Funds first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • Gabelli Funds's Zimmer Biomet position peaked at $25.5M in Q3 2018.
  • 904 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Gabelli Funds's 13F filing for Q2 2026, filed 12 Aug 2026.